Chi-Med Initiates a Phase II Study of Sulfatinib in Second-line Biliary Tract Cancer in China - Yahoo Finance

Chi-Med Initiates a Phase II Study of Sulfatinib in Second-line Biliary Tract Cancer in China Yahoo Finance In addition to the BTC trial, six sulfatinib clinical trials are underway in China and the United States, including two Phase III studies in neuroendocrine tumor patients (SANET-p and SANET-ep) and a Phase II study in thyroid cancer patients. The SANET ... and more »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jAZ0Bu
via IFTTT